VIEMED HEALTHCARE, INC. Shareholders' Equity
VIEMED HEALTHCARE, INC. (VMD) had Shareholders' Equity of $144.03 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-03
- 2026-06-30: Stockholders' Equity Attributable to Parent $144.03M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $143.86M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $141.54M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $133.61M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $144.03M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $143.86M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $141.54M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $133.61M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $139.73M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $134.76M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $131.39M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $124.96M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $119.37M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $116.27M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $113.89M 10-K · filed 2025-03-10 | |
| 2023-09-30 | $108.81M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $104.50M 10-Q · filed 2023-11-01 | |
| 2023-03-31 | $100.04M 10-Q · filed 2024-05-06 | |
| 2022-12-31 | $97.09M 10-Q · filed 2024-05-06 | |
| 2022-09-30 | $93.91M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $93.23M 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $96.04M 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $94.82M 10-K · filed 2024-03-06 | |
| 2021-09-30 | $89.38M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $86.26M 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $83.42M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $81.69M 10-K · filed 2023-03-02 | |
| 2020-09-30 | $75.20M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $71.13M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $48.80M 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $43.70M 10-K · filed 2022-03-07 | |
| 2019-09-30 | $40.33M 10-Q · filed 2020-11-04 | $43.58M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $36.14M 10-Q · filed 2020-11-04 | $39.29M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $33.89M 10-Q · filed 2020-11-04 | $36.55M 10-Q · filed 2019-08-09 |
| 2018-12-31 | $32.57M 10-K · filed 2021-03-03 | $35.03M 10-Q · filed 2019-08-09 |
| 2018-09-30 | $30.39M 10-K · filed 2020-03-04 | $32.78M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $27.50M 10-K · filed 2020-03-04 | $29.68M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $24.74M 10-K · filed 2020-03-04 | $26.65M 10-Q · filed 2019-08-09 |
| 2017-12-31 | $21.95M 10-K · filed 2020-03-04 | $23.74M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |